Evidence map›Paper›PMID 26949749›Full record

ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2016

LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

Brian P Brennan, J Eric Jensen, Christine Perriello, Harrison G Pope, Michael A Jenike, James I Hudson, Scott L Rauch, Marc J Kaufman

Abstract read
In one paragraph

Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  4. Article
  5. Article
  6. Article
  7. In Vivo Brain GSH: MRS Methods and Clinical Applications.Antioxidants (Basel, Switzerland) · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brian P BrennanBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA; Obsessive-Compulsive Disorders Institute, McLean Hospital, Belmont, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
J Eric JensenDepartment of Psychiatry, Harvard Medical School, Boston, MA; McLean Imaging Center, McLean Hospital, Belmont, MA.
Christine PerrielloBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA.
Harrison G PopeBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
Michael A JenikeObsessive-Compulsive Disorders Institute, McLean Hospital, Belmont, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
James I HudsonBiological Psychiatry Laboratory, McLean Hospital, Belmont, MA; Department of Psychiatry, Harvard Medical School, Boston, MA.
Scott L RauchDepartment of Psychiatry, Harvard Medical School, Boston, MA.
Marc J KaufmanDepartment of Psychiatry, Harvard Medical School, Boston, MA; McLean Imaging Center, McLean Hospital, Belmont, MA.
Harvard University · USMcLean Hospital · US

Funding

Glutamatergic Mediators of Antidepressant Response in Major DepressionK23MH092397 · NIMH · MCLEAN HOSPITAL · PI BRENNAN, BRIAN P. · 2011 to 2015
$895k
NIMH NIH HHS K23 MH092397
6 · The paper itself

Abstract

backgroundSeveral lines of evidence support the hypothesis that lower cerebral levels of glutathione (GSH), associated with increased oxidative stress, may contribute to obsessive-compulsive disorder (OCD). However, no studies to date have investigated brain GSH levels in individuals with OCD.

methodsTwenty-nine individuals with OCD and 25 age-, sex-, and race-matched comparison individuals without OCD underwent single voxel 2D J-resolved proton magnetic resonance spectroscopy (MRS) to examine GSH levels in the posterior cingulate cortex (PCC). MRS data were analyzed using LCModel and a simulated basis set. Group metabolite differences referenced to total creatine (Cr), as well as relationships between metabolite ratios and symptom severity as measured by the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), were analyzed using linear regression with adjustment for age, sex, and race.

resultsOne OCD participant failed to produce usable PCC MRS data. We found significantly lower PCC GSH/Cr in OCD participants compared with non-OCD participants (β = -0.027 [95% CI: -0.049 to -5.9 × 10

conclusionsLower PCC GSH/Cr may be indicative of increased oxidative stress secondary to hypermetabolism in this brain region in OCD. Future MRS studies are warranted to investigate GSH levels in other brain regions that comprise the cortico-striato-thalamo-cortical circuit thought to be abnormal in OCD.

Indexed as

glutathioneMRSobsessive-compulsive disorderOCDoxidative stressposterior cingulate cortex

Identifiers

PMID26949749
PMCPMC4774044
OpenAlexW2247825615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.